Divestments
HyTest
HyTest is a recognized producer of high-quality antibodies and antigens for the diagnostic industry all around the world.
Founded in 1994 as a spinoff from a project within Turku University, HyTest is today a high-quality, global antibody and antigen manufacturer and supplier, primarily targeting in vitro diagnostics OEMS and research organizations. The company is headquartered in Turku.
Key Facts
- Sector
Healthcare
- Country
Finland
- Fund
EQT Mid-Market Credit, EQT Mid-Market Credit II
- Entry
2018
- Exit
2020
About HyTest
EQT Credit provided a Unitranche financing to support Summa Equity’s acquisition of HyTest, which is expected to benefit from the attractive market driven by non-cyclical, stable growth drivers.
To HyTest
Do You Want to Know More?
We are eager to explore how we can achieve great things together.